NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundParkinson's disease (PD) can be classified into brain-first and body-first subtypes based on the initial site of α-synuclein pathology. Postmortem studies further suggest that body-first PD may be divided into two phenotypes: sympathetic-predominant subtype (SPS) and parasympathetic-predominant subtype (PPS). However, studies on longitudinal clinical characteristics of the two putative body-first subtypes are limited.ObjectivesWe aim to investigate the clinical features of these subtypes.MethodsIn a cohort of 73 body-first PD patients, we identified 14 patients with orthostatic hypotension (OH) without constipation (putative SPS) and 40 with constipation without OH (putative PPS). Linear mixed models were used to assess disease progression.ResultsOver follow-up, SPS patients exhibited a significantly faster decline in MMSE scores compared with PPS patients (p = 0.045). Progression of other motor and non-motor features was comparable between the groups.ConclusionThese findings indicated that sympathetic-predominant body-first PD may be associated with a more rapid trajectory of cognitive decline, although the observed effect was modest and warrants cautious interpretation.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.